BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/21/2017 7:51:53 AM | Browse: 1127 | Download: 1406
 |
Received |
|
2017-07-14 01:10 |
|
Peer-Review Started |
|
2017-07-17 00:59 |
|
To Make the First Decision |
|
2017-08-10 00:15 |
|
Return for Revision |
|
2017-08-10 08:16 |
|
Revised |
|
2017-08-11 10:21 |
|
Second Decision |
|
2017-08-21 04:32 |
|
Accepted by Journal Editor-in-Chief |
|
2017-08-22 18:27 |
|
Accepted by Company Editor-in-Chief |
|
2017-08-25 14:20 |
|
Articles in Press |
|
2017-08-25 14:20 |
|
Publication Fee Transferred |
|
2017-08-30 03:48 |
 |
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-09-07 03:06 |
|
Publish the Manuscript Online |
|
2017-09-21 07:51 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Anca Trifan, Carol Stanciu, Irina Girleanu, Oana Cristina Stoica, Ana-Maria Singeap, Roxana Maxim, Stefan Andrei Chiriac, Alin Ciobica and Lucian Boiculese |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Carol Stanciu, FRCP (Hon), MD, Professor, “St. Spiridon” Hospital, Institute of Gastroenterology and Hepatology, Independentei Street No. 1, Iasi 700111, Romania. stanciucarol@yahoo.com |
| Key Words |
Proton pump inhibitors; Clostridium difficile infection; Risk; Systematic review; Meta-analysis |
| Core Tip |
A possible association between the use of proton pump inhibitors (PPIs) and the risk of Clostridium difficile infection (CDI) have been suggested by several studies. This meta-analysis, including the largest number of studies published to date found the risk of CDI almost two-times higher in PPIs users than in nonusers. Because all the studies analyzed were observational, the causality could not be confirmed. Nevertheless, clinicians should be aware of such potential association and prescribe the PPIs only where they are clearly indicated. |
| Publish Date |
2017-09-21 07:51 |
| Citation |
Trifan A, Stanciu C, Girleanu I, Stoica OC, Singeap AM, Maxim R, Chiriac SA, Ciobica A, Boiculese L. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. World J Gastroenterol 2017; 23(35): 6500-6515 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i35/6500.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i35.6500 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
